Related Experiment Video
Updated: Apr 20, 2026
08:09
Isolation of Rat Adipose Tissue Mesenchymal Stem Cells for Differentiation into Insulin-producing Cells
Published on: August 29, 2022
8.9K
A modified method of insulin producing cells' generation from bone marrow-derived mesenchymal stem cells
Paweł Czubak1, Agnieszka Bojarska-Junak2, Jacek Tabarkiewicz3
1Chair and Department of Gynaecology and Gynaecological Endocrinology, Medical University of Lublin, Aleje Racławickie 23 (SPSW), 20-037 Lublin, Poland.
Journal of Diabetes Research
|November 19, 2014
Summary
Mesenchymal stem cells (MSCs) can be differentiated into insulin-producing cells (IPCs) using a novel protocol. Optimizing growth factor concentrations enhances IPC differentiation efficiency for potential type 1 diabetes mellitus therapies.
Area of Science:
- Endocrinology
- Stem Cell Biology
- Regenerative Medicine
Background:
- Type 1 diabetes mellitus results from autoimmune destruction of pancreatic beta-cells.
- Current treatments like insulin injections or transplantation are imperfect and have disadvantages.
- Mesenchymal stem cells (MSCs) offer a promising alternative for generating insulin-producing cells.
Purpose of the Study:
- To investigate the potential of bone marrow-derived MSCs for in vitro differentiation into insulin-producing cells (IPCs).
- To establish and optimize a protocol for MSC differentiation into IPCs.
- To determine the optimal concentrations of growth factors for maximizing IPC differentiation efficiency.
Main Methods:
- An 18-day protocol was used to differentiate bone marrow-derived MSCs.
- Differentiated cells were analyzed for insulin production using dithizone staining.
- Proinsulin C-peptide expression in differentiated IPCs was quantified via flow cytometry.
- The influence of varying growth factor concentrations (β-FGF/EGF, activin A/β-cellulin) on differentiation efficiency was assessed.
Main Results:
- Differentiated MSCs formed islet-like cell clusters.
- Insulin presence was confirmed in differentiated cells using dithizone.
- Flow cytometry analysis confirmed proinsulin C-peptide expression.
- Optimal differentiation was achieved with 60 ng/mL β-FGF/EGF and 30 ng/mL activin A/β-cellulin.
- Higher growth factor concentrations did not further increase IPC differentiation.
Conclusions:
- A protocol for differentiating MSCs into IPCs has been established.
- Specific growth factor concentrations are crucial for maximizing differentiation efficiency.
- This method holds potential for developing new therapies for type 1 diabetes mellitus.
